FIELD: organic chemistry, medicine. SUBSTANCE: invention relates to the novel use of anthracyclinone of the formula (A) R1,R2,R3,R4,R5 for treatment of patients with amyloidosis where 
mean corresponding substituents. Some compounds of the formula (I) are new ones. Invention describes also methods of their synthesis and pharmaceutical compositions containing thereof. EFFECT: enhanced effectiveness of amyloidosis treatment. 17 cl, 22 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTHRACYCLINE GLYCOSIDE, METHOD OF ITS SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1992 |
|
RU2118328C1 |
| AZAANTRACYCLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITION | 1996 |
|
RU2159245C2 |
| DERIVATIVES OF 3'-AZIRIDINO-ANTHRACYCLINE, METHODS OF SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2149163C1 |
| ANTHRACYCLIN DERIVATIVES | 1995 |
|
RU2159619C2 |
| BIOLOGICALLY-ACTIVE POLYMER-BOUND ANTHRACYCLINES, INTERMEDIATES, PREPARATION METHODS, AND PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2145965C1 |
| FLUORINATED DERIVATIVES OF 17β-SUBSTITUTED-4-AZA--5α-ANDROSTANE- -3-ONE, PHARMACEUTICAL COMPOSITION | 1993 |
|
RU2125061C1 |
| ANTHRACYCLINE GLYCOSIDE AND METHOD OF ITS SYNTHESIS | 1992 |
|
RU2081878C1 |
| CONJUGATES OF ANTHRACYCLINE, METHOD FOR THEIR PRODUCTION AND USING | 1992 |
|
RU2107690C1 |
| BINDING AGENT FOR BIOACTIVE PREPARATIONS, METHOD OF ITS SYNTHESIS AND PHARMACEUTICAL COMPOSITIONS | 1991 |
|
RU2116087C1 |
| 7-HALO- AND 7β, 8β--METHANOTAXOLS, PHARMACEUTICAL COMPOSITION, INTERMEDIATE COMPOUNDS AND METHODS OF SYNTHESIS OF INTERMEDIATE COMPOUNDS | 1993 |
|
RU2125996C1 |
